Quarterly Financial Data (Unaudited) (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 27, 2016 |
Aug. 31, 2016 |
Dec. 31, 2016 |
Sep. 30, 2016 |
Jun. 30, 2016 |
Mar. 31, 2016 |
Dec. 31, 2015 |
Sep. 30, 2015 |
Jun. 30, 2015 |
Mar. 31, 2015 |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
| Quarterly Financial Information Disclosure [Abstract] | |||||||||||||
| Revenue | $ 156,764,000 | $ 146,909,000 | $ 112,265,000 | $ 113,817,000 | $ 113,235,000 | $ 110,114,000 | $ 102,376,000 | $ 100,305,000 | $ 529,755,000 | $ 426,030,000 | $ 387,735,000 | ||
| Cost of sales | 110,268,000 | 103,348,000 | 75,086,000 | 76,768,000 | 72,191,000 | 71,456,000 | 66,083,000 | 69,426,000 | 365,470,000 | 279,156,000 | 281,873,000 | ||
| Sales and marketing | 11,388,000 | 8,390,000 | 6,491,000 | 4,672,000 | 4,647,000 | 4,819,000 | 4,964,000 | 3,275,000 | 30,941,000 | 17,705,000 | 13,287,000 | ||
| Product development (7) | 12,640,000 | 7,916,000 | 8,416,000 | 8,746,000 | 7,163,000 | 7,766,000 | 6,451,000 | 7,230,000 | 37,718,000 | 28,610,000 | 23,010,000 | ||
| General and administrative (1) (2) (3) | 32,800,000 | 44,728,000 | 18,447,000 | 19,220,000 | 23,418,000 | 18,602,000 | 17,576,000 | 18,119,000 | 115,195,000 | 77,715,000 | 69,743,000 | ||
| Provision for legal settlements | 1,758,000 | 1,545,000 | 38,142,000 | 2,001,000 | 0 | 3,500,000 | 750,000 | 0 | |||||
| Amortization of intangible assets | 11,593,000 | 9,166,000 | 7,486,000 | 7,403,000 | 7,720,000 | 7,286,000 | 6,005,000 | 5,983,000 | 35,648,000 | 26,994,000 | 24,552,000 | ||
| Goodwill impairment | 64,000,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 64,000,000 | 0 | 0 | ||
| Restructuring charges | 0 | 0 | 0 | 0 | 43,000 | 66,000 | 0 | 302,000 | 0 | 411,000 | 4,223,000 | ||
| Total operating expenses | 244,447,000 | 175,093,000 | 154,068,000 | 118,810,000 | 115,182,000 | 113,495,000 | 101,829,000 | 104,335,000 | 692,418,000 | 434,841,000 | 424,718,000 | ||
| Loss from operations | (87,683,000) | (28,184,000) | (41,803,000) | (4,993,000) | (1,947,000) | (3,381,000) | 547,000 | (4,030,000) | (162,663,000) | (8,811,000) | (36,983,000) | ||
| Interest expense, net | (10,369,000) | (6,412,000) | (613,000) | (804,000) | (861,000) | (803,000) | (583,000) | (245,000) | (18,198,000) | (2,492,000) | 88,000 | ||
| Income from equity method investments | 1,764,000 | 2,065,000 | 0 | 0 | 0 | 0 | 0 | 0 | 3,829,000 | 0 | (1,500,000) | ||
| Change in fair value of derivatives | 7,533,000 | 1,191,000 | 10,926,000 | 5,865,000 | (1,928,000) | (1,877,000) | 14,789,000 | 954,000 | 25,515,000 | 11,938,000 | (6,955,000) | ||
| Other income (expense), net | (1,703,000) | 631,000 | (5,934,000) | 680,000 | 675,000 | (576,000) | (443,000) | (796,000) | (6,326,000) | (1,140,000) | (1,270,000) | ||
| Income (loss) before income taxes | (90,458,000) | (30,709,000) | (37,424,000) | 748,000 | (4,061,000) | (6,637,000) | 14,310,000 | (4,117,000) | (157,843,000) | (505,000) | (46,620,000) | ||
| Income tax expense (benefit) (2) | 1,256,000 | (50,063,000) | 736,000 | 3,160,000 | 749,000 | 235,000 | 1,323,000 | (686,000) | (44,911,000) | 1,621,000 | 10,574,000 | ||
| Net income (loss) | $ (91,714,000) | $ 19,354,000 | $ (38,160,000) | $ (2,412,000) | $ (4,810,000) | $ (6,872,000) | $ 12,987,000 | $ (3,431,000) | $ (112,932,000) | $ (2,126,000) | $ (57,194,000) | ||
| Net income (loss) per share - basic (in usd per share) | $ (1.07) | $ 0.23 | $ (0.49) | $ (0.03) | $ (0.06) | $ (0.09) | $ 0.17 | $ (0.04) | $ (1.39) | $ (0.03) | $ (0.78) | ||
| Net income (loss) per share - diluted (in usd per share) | $ (1.07) | $ 0.23 | $ (0.49) | $ (0.03) | $ (0.06) | $ (0.09) | $ (0.02) | $ (0.06) | $ (1.39) | $ (0.18) | $ (0.78) | ||
| Weighted average common shares outstanding - basic (in shares) | 85,369,000 | 82,874,000 | 78,127,000 | 78,643,000 | 78,476,000 | 77,753,000 | 77,111,000 | 76,874,000 | 81,269,000 | 77,558,000 | 73,300,000 | ||
| Weighted average common shares outstanding - diluted (in shares) | 85,369,000 | 85,081,000 | 78,127,000 | 78,643,000 | 78,476,000 | 77,753,000 | 78,518,000 | 78,725,000 | 81,269,000 | 78,394,000 | 73,300,000 | ||
| Business Acquisition [Line Items] | |||||||||||||
| Increase (decrease) in deferred tax asset | $ (9,930,000) | $ (19,060,000) | $ 22,877,000 | ||||||||||
| Write-off of related party receivables | $ 2,624,000 | $ 797,000 | $ 5,539,000 | ||||||||||
| Repurchase and retirement of common stock (in shares) | 600,000 | 600,000 | |||||||||||
| Repurchase and retirement of common stock | $ 5,200,000 | $ 5,219,000 | |||||||||||
| Other Income (Expense) | |||||||||||||
| Business Acquisition [Line Items] | |||||||||||||
| Write-off of related party receivables | 4,400,000 | ||||||||||||
| Other Income (Expense) | Internally developed software | |||||||||||||
| Business Acquisition [Line Items] | |||||||||||||
| Impairment of intangible assets | $ 3,200,000 | 900,000 | |||||||||||
| Q3 2015 Acquisitions | |||||||||||||
| Business Acquisition [Line Items] | |||||||||||||
| Transaction and integration expenses | $ 1,300,000 | ||||||||||||
| Emerging Markets Communications LLC | |||||||||||||
| Business Acquisition [Line Items] | |||||||||||||
| Increase (decrease) in deferred tax asset | $ (53,900,000) | ||||||||||||
| Deferred tax liabilities, foreign subsidiaries' contribution to pretax income | 4,800,000 | ||||||||||||
| Deferred tax liabilities, withholding taxes | $ 2,700,000 | ||||||||||||
| Transaction and integration expenses | $ 12,700,000 | $ 1,900,000 | $ 800,000 | $ 1,800,000 | $ 15,400,000 | ||||||||
| Emerging Markets Communications LLC | Common Stock | |||||||||||||
| Business Acquisition [Line Items] | |||||||||||||
| Business acquisition, shares issued | 5,466,886 | ||||||||||||
| Common Stock | |||||||||||||
| Business Acquisition [Line Items] | |||||||||||||
| Repurchase and retirement of common stock (in shares) | 614,000 | ||||||||||||
| UMG Recordings | Common Stock | |||||||||||||
| Business Acquisition [Line Items] | |||||||||||||
| Shares issued in period (in shares) | 1,800,000 | ||||||||||||
| X | ||||||||||
- Definition Deferred Tax Liabilities, Withholding Taxes On Foreign Subsidiaries No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiaries and other recognized entities not within the country of domicile of the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The net amount of nonoperating interest income (expense). No definition available.
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Number of shares that have been repurchased and retired during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|